Stock CRDL CARDIOL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Cardiol Therapeutics Inc.

Equities

CRDL

CA14161Y2006

Delayed Toronto S.E.
Other stock markets
 03:28:11 2024-05-17 pm EDT 		5-day change 1st Jan Change
2.95 CAD -8.39% Intraday chart for Cardiol Therapeutics Inc. +0.68% +168.18%
May. 14 Cardiol Therapeutics Says Phase II ARCHER Trial Presented at World Congress on Acute Heart Failure MT
Apr. 22 HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CRDL Stock
  4. Revisions Cardiol Therapeutics Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW